1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porters Fiver Forces Analysis 39
3 Segmentation of Global Market by Service 43
3.1 Market Overview by Service 43
3.2 Genotyping 45
3.3 SNP Identification 46
3.4 Diagnostics 47
3.5 Other Services 49
4 Segmentation of Global Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Polymerase Chain Reaction (PCR) 52
4.3 Microarray 53
4.4 Sequencing 54
4.5 Electrophoresis 55
4.6 Mass Spectrometry 56
4.7 Other Technologies 57
5 Segmentation of Global Market by Application 58
5.1 Market Overview by Application 58
5.2 Oncology 60
5.3 Infectious Diseases 61
5.4 Neurology/Psychiatry 62
5.5 Cardiovascular 64
5.6 Pain Management 65
5.7 Other Applications 66
6 Segmentation of Global Market by End User 67
6.1 Market Overview by End User 67
6.2 Hospitals and Clinics 69
6.3 Pharmaceutical Companies 70
6.4 Research Institutes 71
7 Segmentation of Global Market by Region 72
7.1 Geographic Market Overview 2019-2030 72
7.2 North America Market 2019-2030 by Country 78
7.2.1 Overview of North America Market 78
7.2.2 U.S. 82
7.2.3 Canada 86
7.2.4 Mexico 88
7.3 European Market 2019-2030 by Country 90
7.3.1 Overview of European Market 90
7.3.2 Germany 94
7.3.3 UK 96
7.3.4 France 98
7.3.5 Spain 100
7.3.6 Italy 102
7.3.7 Russia 104
7.3.8 Rest of European Market 106
7.4 Asia-Pacific Market 2019-2030 by Country 108
7.4.1 Overview of Asia-Pacific Market 108
7.4.2 Japan 112
7.4.3 China 115
7.4.4 Australia 117
7.4.5 India 119
7.4.6 South Korea 121
7.4.7 Rest of APAC Region 123
7.5 South America Market 2019-2030 by Country 125
7.5.1 Argentina 128
7.5.2 Brazil 130
7.5.3 Chile 132
7.5.4 Rest of South America Market 134
7.6 MEA Market 2019-2030 by Country 135
7.6.1 UAE 138
7.6.2 Saudi Arabia 140
7.6.3 South Africa 142
7.6.4 Other National Markets 144
8 Competitive Landscape 145
8.1 Overview of Key Vendors 145
8.2 New Product Launch, Partnership, Investment, and M&A 149
8.3 Company Profiles 150
23andMe, Inc. 150
Abbott Laboratories 152
Admera Health, LLC 153
Agena Biosciences, Inc. 154
Astra Zeneca PLC 155
Bayer AG 156
Becton, Dickinson and Company 157
Cancer Genetics, Inc. 158
Dynamic DNA Laboratories 159
Empire Genomics LLC 160
F. Hoffmann-La Roche Ltd 161
geneOmbio Technologies Pvt Ltd. 162
Genomic Health, Inc. 163
Illumina, Inc. 164
Laboratory Corporation of America Holdings 165
Myriad Genetics Inc. 166
Oneome LLC 167
Opko Health, Inc. 168
Pathway Genomics Corporation 169
QIAGEN N.V. 170
Quest Diagnostics Incorporated 171
Teva Pharmaceuticals Industries Ltd. 172
Thermo Fisher Scientific Inc. 173
Transgenomic, Inc. 174
9 Investing in Global Market: Risk Assessment and Management 175
9.1 Risk Evaluation of Global Market 175
9.2 Critical Success Factors (CSFs) 178
Related Reports and Products 181